Drug profile · INN
imetelstat sodium
RYTELO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
imetelstat sodium (RYTELO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN imetelstat sodium
Brand RYTELO
Route INTRAVENOUS
Formulation POWDER
Frequently asked questions
What is imetelstat sodium?
imetelstat sodium (RYTELO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for imetelstat sodium?
RYTELO is a marketed brand name for imetelstat sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of imetelstat sodium?
imetelstat sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.